Cite
Andexanet Alfa (Andexxa®) for the Reversal of Direct Oral Anticoagulants.
MLA
Momin, Jayed H., et al. “Andexanet Alfa (Andexxa®) for the Reversal of Direct Oral Anticoagulants.” P&T: A Peer-Reviewed Journal for Managed Care & Formulary Management, vol. 44, no. 9, Sept. 2019, pp. 530–49. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=138467379&authtype=sso&custid=ns315887.
APA
Momin, J. H., Hughes, G. J., & Candidate, P. (2019). Andexanet Alfa (Andexxa®) for the Reversal of Direct Oral Anticoagulants. P&T: A Peer-Reviewed Journal for Managed Care & Formulary Management, 44(9), 530–549.
Chicago
Momin, Jayed H., Gregory J. Hughes, and PharmD Candidate. 2019. “Andexanet Alfa (Andexxa®) for the Reversal of Direct Oral Anticoagulants.” P&T: A Peer-Reviewed Journal for Managed Care & Formulary Management 44 (9): 530–49. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=138467379&authtype=sso&custid=ns315887.